Company profile for Aquestive Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Aquestive Therapeutics (formerly MonoSol Rx) is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. Our team asks questions and identifies issues others have not, and builds solutions that empower patients and their caregivers with better ways to manage complex diseases. Our initial focus, supported by our current appro...
Aquestive Therapeutics (formerly MonoSol Rx) is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. Our team asks questions and identifies issues others have not, and builds solutions that empower patients and their caregivers with better ways to manage complex diseases. Our initial focus, supported by our current approved products and late stage pipeline, is to address immediate CNS challenges.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
30 Technology Drive Warren, NJ 07059
Telephone
Telephone
908-941-1900
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/24/3193375/0/en/Aquestive-Therapeutics-to-Participate-in-the-Piper-Sandler-37th-Annual-Healthcare-Conference.html

GLOBENEWSWIRE
24 Nov 2025

https://www.globenewswire.com/news-release/2025/11/05/3181904/0/en/Aquestive-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
05 Nov 2025

https://www.globenewswire.com/news-release/2025/10/30/3177236/0/en/Aquestive-Therapeutics-to-Attend-2025-ACAAI-Annual-Meeting.html

GLOBENEWSWIRE
30 Oct 2025

https://www.globenewswire.com/news-release/2025/10/27/3174425/0/en/Aquestive-Therapeutics-to-Report-Third-Quarter-2025-Financial-Results-and-Recent-Business-Highlights-on-November-5-and-Host-Conference-Call-on-November-6-at-8-00-a-m-ET.html

GLOBENEWSWIRE
27 Oct 2025

https://www.globenewswire.com/news-release/2025/10/08/3163180/0/en/Aquestive-Therapeutics-Broadens-Patent-Estate-for-Anaphylm.html

GLOBENEWSWIRE
08 Oct 2025

https://www.globenewswire.com/news-release/2025/08/26/3139129/0/en/Aquestive-Therapeutics-to-Participate-in-Upcoming-September-Investor-Conferences.html

GLOBENEWSWIRE
26 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty